Loading clinical trials...
Loading clinical trials...
A Study to Evaluate the Efficacy and Safety of Ferric Citrate Tablet for the Treatment of Hyperphosphatemia in Patients With Chronic Kidney Disease Undergoing Hemodialysis
Conditions
Interventions
Ferric citrate tablet
Sevelamer carbonate tablet
Locations
20
China
The first affiliated hospital of Baotou medical college
Baotou, China
Beijing Tongren Hospital
Beijing, China
Peking Union Medical College Hospital
Beijing, China
The Second Xiangya Hospital of Central South University
Changsha, China
Xiangya Hospital Central South University
Changsha, China
The second hospital of Dalian medical university
Dalian, China
Start Date
May 24, 2019
Primary Completion Date
September 13, 2022
Completion Date
September 13, 2022
Last Updated
April 17, 2024
NCT07157397
NCT06366230
NCT06933472
NCT07146854
NCT04163614
NCT04580420
Lead Sponsor
Sinomune Pharmaceutical Co., Ltd
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions